CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018		Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	$ 57,917	$ 43,003		$ 37,976
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	25,809	24,104		23,916
Amortization of deferred financing cost	225	333		343
Increase (decrease) to allowance for doubtful accounts	(295)	330		972
Increase to inventory reserves	4,858	3,978		3,300
Amortization of deferred gain on sale of buildings	0	(218)		(1,048)
Gain on sale of property, plant and equipment	0	(3,997)		(15)
Equity (income) loss from joint ventures	(2,865)	768	[1]	602	[1]
Employee Stock Ownership Plan allocation	2,519	2,557		2,159
Stock-based compensation	6,917	7,998		7,638
(Increase) decrease in deferred income taxes	4,736	(10,046)		19,059
Increase (decrease) in tax valuation allowance	358	22		(128)
Loss on discontinued operations, net of tax	11,134	13,851		5,654
Change in assets and liabilities:
(Increase) decrease in accounts receivable	17,929	(13,699)		(5,100)
Increase in inventories	(17,901)	(30,199)		(13,901)
(Increase) decrease in prepaid expenses and other current assets	(8,296)	4,926		(4,869)
Increase (decrease) in accounts payable	(1,950)	16,894		(7,186)
Increase (decrease) in sundry payables and accrued expenses	(18,097)	8,407		(6,015)
Net change in other assets and liabilities	(6,070)	1,246		1,260
Net cash provided by operating activities	76,928	70,258		64,617
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisitions of and investments in businesses	(43,490)	(9,852)		(6,808)
Net proceeds from sale of Grapevine, Texas facility	4,801	0		0
Capital expenditures	(16,185)	(20,141)		(24,442)
Other investing activities	62	107		22
Net cash used in investing activities	(54,812)	(29,886)		(31,228)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net borrowings (repayments) under line-of-credit agreements	8,771	(13,311)		2,188
Net borrowings (repayments) of other debt and lease obligations	(911)	1,115		4,065
Purchase of treasury stock	(10,738)	(14,886)		(24,376)
Increase (decrease) in overdraft balances	93	275		(534)
Payments of debt issuance costs	0	(460)		0
Dividends paid	(20,593)	(18,854)		(17,287)
Net cash used in financing activities	(23,378)	(46,121)		(35,944)
Effect of exchange rate changes on cash	496	(436)		82
Net decrease in cash and cash equivalents	(766)	(6,185)		(2,473)
CASH AND CASH EQUIVALENTS at beginning of year	11,138	17,323		19,796
CASH AND CASH EQUIVALENTS at end of year	10,372	11,138		17,323
Cash paid during the year for:
Interest	5,030	3,738		1,944
Income taxes	22,267	15,353		34,543
Noncash investing activity:
Accrual for additional investment in China joint venture	0	0		5,740
Receivable related to net proceeds from sale of Grapevine, Texas facility	$ 0	$ 4,801		$ 0

[1] Year ended December 31, 2018 and 2017 includes a noncash impairment charge of approximately $1.7 million and $1.8 million, respectively, related to our minority interest investment in Orange Electronic Co., Ltd.  (See Note 10, “Investments in Unconsolidated Affiliates” for additional information).